1,204 results on '"Morimoto, Satoshi"'
Search Results
2. Prediction of endogenous mineralocorticoid receptor activity by depressor effects of mineralocorticoid receptor antagonists in patients with primary aldosteronism
3. Comparisons of risk factors for post-treatment renal dysfunction between the two major subtypes of primary aldosteronism
4. Highly sensitive indirect competitive enzyme-linked immunosorbent assay based on a monoclonal antibody against saikosaponin b2 for quality control of Kampo medicines containing Bupleuri radix
5. Cardiovascular risk assessments in patients with cortisol-producing adenoma: impact of clinical features and genetic characteristics
6. Effects of esaxerenone, a nonsteroidal mineralocorticoid receptor blocker, independent of urinary sodium/potassium ratio and salt intake
7. Time-dependent changes in P2Y12 reaction unit values for predicting the different types of cardiovascular events in patients with ischemic heart disease
8. Monoclonal antibody-based enzyme-linked immunosorbent assay for quantification of majonoside R2 as an authentication marker for Nngoc Linh and Lai Chau ginsengs
9. An aptamer-based fluorometric method for the rapid berberine detection in Kampo medicines
10. Lowering of blood pressure by chemical ablation of the unilateral adrenal gland in spontaneously hypertensive rats
11. Serum VEGF-A levels on admission in COVID-19 patients correlate with SP-D and neutrophils, reflecting disease severity: A prospective study
12. Advanced quality assessment of Sanshishi (Gardenia jasminoides Ellis) and Kampo medicines using a monoclonal antibody against geniposide
13. Long COVID and hypertension-related disorders: a report from the Japanese Society of Hypertension Project Team on COVID-19
14. COVID-19 pandemic and hypertension: an updated report from the Japanese Society of Hypertension project team on COVID-19
15. Investigation of the small-balloon technique as a method for retrieving dislodged stents
16. Impact of Abdominal Fat Distribution on Mortality and Its Changes Over Time in Patients Undergoing Hemodialysis: A Prospective Cohort Study
17. Urinary free cortisol excretion is associated with lumbar bone density in patients with adrenal Cushing’s syndrome
18. Characteristics of neutralizing antibody titers of the SARS-CoV-2 vaccine in maintenance hemodialysis patients
19. Acromegaly complicated with hypercortisolemia
20. Comparison of antihypertensive effects between eplerenone and esaxerenone, mineralocorticoid receptor antagonists, in patients with primary aldosteronism
21. Lateral flow immunoassay for small-molecules detection in phytoproducts: a review
22. Optimal blood pressure target to prevent severe hypertension in pregnancy: A systematic review and meta-analysis
23. Late age at menopause positively associated with obesity-mediated hypertension
24. Assessment of cardiovascular disease risk by plasma renin activity changes in patients with primary aldosteronism on mineralocorticoid receptor antagonist treatment
25. Comparison of the usefulness of the cardio-ankle vascular index and augmentation index as an index of arteriosclerosis in patients with essential hypertension
26. Effects of mineralocorticoid receptor antagonists on sex hormones and body composition in patients with primary aldosteronism
27. Open sandwich fluorescence-linked immunosorbent assay for detection of soy isoflavone glycosides
28. Relevance of ChatGPT’s Responses to Common Hypertension-Related Patient Inquiries
29. Possible Association Between Body Temperature and B-Type Natriuretic Peptide in Patients With Cardiovascular Diseases
30. Simultaneous rapid detection of glycyrrhizin and sennoside A in Daiokanzoto samples by lateral flow immunoassay.
31. Correction: Urinary free cortisol excretion is associated with lumbar bone density in patients with adrenal Cushing’s syndrome
32. Comparisons of risk factors for post-treatment renal dysfunction between the two major subtypes of primary aldosteronism
33. Lowering of blood pressure by chemical ablation of the unilateral adrenal gland in spontaneously hypertensive rats
34. Effect of Growth Hormone Deficiency Caused by Nonfunctioning Pituitary Masses on Serum C-reactive Protein Levels
35. THU069 Growth Hormone Secretion And Serum High-sensitivity C-reactive Protein Levels In Adult Patients With Non-functioning Pituitary Tumors
36. Cosyntropin stimulation in adrenal vein sampling improves the judgment of successful adrenal vein catheterization and outcome prediction for primary aldosteronism
37. Comparison of the shortened and standard saline infusion tests for primary aldosteronism diagnostics
38. Serum soluble (pro)renin receptor level as a prognostic factor in patients undergoing maintenance hemodialysis
39. Management of primary aldosteronism and mineralocorticoid receptor-associated hypertension
40. Serum-soluble (pro)renin receptor concentration as a biomarker for organ damage in primary aldosteronism
41. Efficacy of esaxerenone—a nonsteroidal mineralocorticoid receptor blocker—on nocturnal hypertension
42. Magnetic particles-based enzyme immunoassay for rapid determination of secoiridoid glycoside, amarogentin
43. Improvement of heavy and light chain assembly by modification of heavy chain constant region 1 (CH1): Application for the construction of an anti-paclitaxel fragment antigen-binding (Fab) antibody
44. Serum VEGF Levels on Admission in COVID-19 Patients Correlate with SP-D and Neutrophils, Reflecting Disease Severity: A Prospective Study
45. A Novel Class of Plant Type III Polyketide Synthase Involved in Orsellinic Acid Biosynthesis from Rhododendron dauricum
46. Characteristics of visit-to-visit blood pressure variability in hemodialysis patients
47. Influences of changes in obesity-related parameters on progression of arteriosclerosis in hemodialysis patients: a prospective cohort study
48. Soluble (Pro)Renin Receptor Level in Patients with Severe Obesity Is Associated with Visceral Adiposity and Is Involved with Insulin Resistance and Renal Injury
49. A negative association between growth hormone secretion and inflammation in adult patients with non-functioning pituitary mass
50. The effect of varying the peptide linker length in a single chain variable fragment antibody against wogonin glucuronide
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.